Nektar Therapeutics (NASDAQ:NKTR)

13.30
Delayed Data
As of Mar 05
 -0.09 / -0.67%
Today’s Change
10.10
Today|||52-Week Range
17.53
-14.19%
Year-to-Date

Today’s Trading

Previous close13.39
Today’s open13.50
Day’s range13.23 - 13.66
Volume939,744
Average volume (3 months)973,748
Market cap$1.8B
Dividend yield--
Data as of 03/05/2015

Growth & Valuation

Earnings growth (last year)+70.00%
Earnings growth (this year)-8.93%
Earnings growth (next 5 years)+42.46%
Revenue growth (last year)+34.77%
P/E ratioNM
Price/Sales9.80
Price/Book--

Competitors

 Today’s
change
Today’s
% change
FGENFibroGen Inc+0.77+2.60%
INCRINC Research Holding...+0.40+1.36%
PRAHPRA Health Sciences ...+0.35+1.15%
ARIAARIAD Pharmaceutical...+0.15+1.85%
Data as of 03/05/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)$0.37
Annual revenue (last year)$200.7M
Annual profit (last year)-$53.9M
Net profit margin-26.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Class I Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account